HUT75099A - New thiazolidindiones, process for their preparation and drugs containing them - Google Patents

New thiazolidindiones, process for their preparation and drugs containing them

Info

Publication number
HUT75099A
HUT75099A HU9503376A HU9503376A HUT75099A HU T75099 A HUT75099 A HU T75099A HU 9503376 A HU9503376 A HU 9503376A HU 9503376 A HU9503376 A HU 9503376A HU T75099 A HUT75099 A HU T75099A
Authority
HU
Hungary
Prior art keywords
denotes
pct
alkyl
heteroatoms
sec
Prior art date
Application number
HU9503376A
Other languages
English (en)
Other versions
HU217065B (hu
HU9503376D0 (en
Inventor
Peter Freund
Alfred Mertens
Hans-Peter Wolff
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of HU9503376D0 publication Critical patent/HU9503376D0/hu
Publication of HUT75099A publication Critical patent/HUT75099A/hu
Publication of HU217065B publication Critical patent/HU217065B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU9503376A 1993-05-25 1994-05-19 Tiazolidindionok, eljárás előállításukra, és az ezeket tartalmazó gyógyszerkészítmények HU217065B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4317320A DE4317320A1 (de) 1993-05-25 1993-05-25 Neue Thiazolidindione und diese enthaltende Arzneimittel

Publications (3)

Publication Number Publication Date
HU9503376D0 HU9503376D0 (en) 1996-01-29
HUT75099A true HUT75099A (en) 1997-04-28
HU217065B HU217065B (hu) 1999-11-29

Family

ID=6488833

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9503376A HU217065B (hu) 1993-05-25 1994-05-19 Tiazolidindionok, eljárás előállításukra, és az ezeket tartalmazó gyógyszerkészítmények

Country Status (25)

Country Link
US (1) US5599826A (hu)
EP (1) EP0700397B1 (hu)
JP (1) JP3162721B2 (hu)
KR (1) KR100243783B1 (hu)
CN (1) CN1040324C (hu)
AT (1) ATE223409T1 (hu)
AU (1) AU682699B2 (hu)
CA (1) CA2163028C (hu)
CL (1) CL2004001167A1 (hu)
CY (1) CY2415B1 (hu)
CZ (1) CZ285927B6 (hu)
DE (2) DE4317320A1 (hu)
DK (1) DK0700397T3 (hu)
ES (1) ES2180581T3 (hu)
FI (1) FI955685A0 (hu)
HU (1) HU217065B (hu)
NO (1) NO307832B1 (hu)
NZ (1) NZ267410A (hu)
PL (1) PL180046B1 (hu)
PT (1) PT700397E (hu)
RO (1) RO114328B1 (hu)
RU (1) RU2122002C1 (hu)
SK (1) SK282618B6 (hu)
UA (1) UA41362C2 (hu)
WO (1) WO1994027995A1 (hu)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07138258A (ja) * 1993-11-16 1995-05-30 Taiho Yakuhin Kogyo Kk チアゾリジンジオン誘導体又はその塩
KR100429950B1 (ko) * 1995-07-31 2004-06-16 시오노기세이야쿠가부시키가이샤 포스포리파제에이2저해활성을갖는피롤리딘유도체
JPH09176162A (ja) * 1995-12-22 1997-07-08 Toubishi Yakuhin Kogyo Kk チアゾリジンジオン誘導体及びその製造法並びにそれを含む医薬組成物
DE19619819A1 (de) * 1996-05-16 1997-11-20 Boehringer Mannheim Gmbh Neue Thiazolidindione, Verfahren zu ihrer Herstellung und diese enthaltenden Arzneimittel
DE19711616A1 (de) * 1997-03-20 1998-09-24 Boehringer Mannheim Gmbh Verbessertes Verfahren zur Herstellung von Thiazolidindionen
DE19711617A1 (de) * 1997-03-20 1998-09-24 Boehringer Mannheim Gmbh Neue Thiazolidindione, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US6028088A (en) * 1998-10-30 2000-02-22 The University Of Mississippi Flavonoid derivatives
GB9824893D0 (en) * 1998-11-12 1999-01-06 Smithkline Beckman Corp Novel method of treatment
AU1740900A (en) * 1998-11-20 2000-06-13 Genentech Inc. Method of inhibiting angiogenesis
DK1078923T3 (da) 1999-08-02 2006-07-10 Hoffmann La Roche Fremgangsmåde til fremstilling af benzothiophenderivater
US6531609B2 (en) 2000-04-14 2003-03-11 Hoffmann-La Roche Inc. Process for the preparation of thiazolidinedione derivatives
DK1283830T3 (da) * 2000-05-08 2008-08-25 Hoffmann La Roche Para-amin-substituerede phenylamidglucokinase-aktivatorer
PL203804B1 (pl) 2000-06-27 2009-11-30 Hoffmann La Roche Sposób wytwarzania kompozycji farmaceutycznej w postaci spoistej, płytkowej, piankowej, gąbczastej lub ciastowatej struktury i kompozycja farmaceutyczna otrzymana tym sposobem
IL156505A0 (en) * 2000-12-25 2004-01-04 Ono Pharmaceutical Co Dihydronaphthalene derivative compounds and agent comprising the derivative as active ingredient
US7323481B2 (en) * 2001-04-06 2008-01-29 Hoffmann-La Roche Inc. Thiazolidinediones alone or in combination with other therapeutic agents for inhibiting or reducing tumour growth
CZ20033037A3 (cs) 2001-05-15 2004-06-16 F. Hoffmann-La Roche Ag Karboxylové kyselinou odvozené od substituovaných oxazolových derivátů pro použití jako PPAR-alfa a -gama aktivátory při léčbě diabetu
JP2003040877A (ja) * 2001-07-24 2003-02-13 Sumika Fine Chemicals Co Ltd 5−[6−(2−フルオロベンジルオキシ)−2−ナフチル]メチル−2,4−チアゾリジンジオンの製造方法及びその精製方法
US7102000B2 (en) * 2002-03-08 2006-09-05 Incyte San Diego Inc. Heterocyclic amide derivatives for the treatment of diabetes and other diseases
CN100402510C (zh) * 2002-07-03 2008-07-16 霍夫曼-拉罗奇有限公司 噁唑衍生物及其作为胰岛素敏化剂的应用
RU2296754C2 (ru) * 2002-08-30 2007-04-10 Ф.Хоффманн-Ля Рош Аг НОВЫЕ СОЕДИНЕНИЯ 2-АРИЛТИАЗОЛА В КАЧЕСТВЕ АГОНИСТОВ PPAR α И PPAR γ
SI1539746T1 (sl) * 2002-09-12 2007-04-30 Hoffmann La Roche Spojine n-substituirane-1h-indol-5-propionske kisline kot agonisti ppar, ki so uporabne za zdravljenje diabetesa
KR100713266B1 (ko) * 2002-11-25 2007-05-04 에프. 호프만-라 로슈 아게 인돌릴 유도체
MXPA05013732A (es) * 2003-06-26 2006-03-08 Hoffmann La Roche Proceso para preparacion de sensibilizador de insulina y compuesto intermediario del mismo.
CN101693202B (zh) * 2009-10-21 2011-04-20 沧州那瑞化学科技有限公司 盐酸吡咯列酮关键中间体加氢反应催化剂及加氢反应方法
US20150004144A1 (en) 2011-12-02 2015-01-01 The General Hospital Corporation Differentiation into brown adipocytes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
WO1986007056A1 (en) * 1985-05-21 1986-12-04 Pfizer Inc. Hypoglycemic thiazolidinediones
GB8713861D0 (en) * 1987-06-13 1987-07-15 Beecham Group Plc Compounds
US4912909A (en) * 1988-03-04 1990-04-03 Kurt H. Volk, Inc. Direct mail article with mailable reply card
HU217432B (hu) * 1988-03-08 2000-01-28 Pfizer Inc. Eljárás tiazolidin-dion-származékok és az ezeket tartalmazó gyógyszerkészítmények előállítására, a vegyületek és a készítmények
WO1992000967A1 (fr) * 1990-07-03 1992-01-23 Yamanouchi Pharmaceutical Co., Ltd. Compose biheterocyclique
FR2688220A1 (fr) * 1992-03-06 1993-09-10 Adir Nouveaux derives de thiazolidine-2,4-dione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
NO954762D0 (no) 1995-11-24
WO1994027995A1 (de) 1994-12-08
EP0700397A1 (de) 1996-03-13
CZ299995A3 (en) 1996-03-13
SK146195A3 (en) 1996-06-05
DE4317320A1 (de) 1994-12-01
HU217065B (hu) 1999-11-29
RU2122002C1 (ru) 1998-11-20
PL180046B1 (en) 2000-12-29
FI955685A (fi) 1995-11-24
DK0700397T3 (da) 2003-01-06
SK282618B6 (sk) 2002-10-08
FI955685A0 (fi) 1995-11-24
CL2004001167A1 (es) 2005-05-20
UA41362C2 (uk) 2001-09-17
JPH08510456A (ja) 1996-11-05
CN1040324C (zh) 1998-10-21
JP3162721B2 (ja) 2001-05-08
CN1124488A (zh) 1996-06-12
EP0700397B1 (de) 2002-09-04
NO954762L (no) 1995-11-24
ES2180581T3 (es) 2003-02-16
NO307832B1 (no) 2000-06-05
NZ267410A (en) 1996-12-20
AU682699B2 (en) 1997-10-16
KR100243783B1 (ko) 2000-03-02
KR960702460A (ko) 1996-04-27
PT700397E (pt) 2002-12-31
CY2415B1 (en) 2004-11-12
DE59410181D1 (de) 2002-10-10
HU9503376D0 (en) 1996-01-29
CZ285927B6 (cs) 1999-11-17
AU6970494A (en) 1994-12-20
US5599826A (en) 1997-02-04
CA2163028C (en) 2003-11-25
ATE223409T1 (de) 2002-09-15
RO114328B1 (ro) 1999-03-30
PL311752A1 (en) 1996-03-18
CA2163028A1 (en) 1994-12-08

Similar Documents

Publication Publication Date Title
HUT75099A (en) New thiazolidindiones, process for their preparation and drugs containing them
NO952129L (no) Oksalylamino-benzofuran- og benzotienyl-derivater
ATE63914T1 (de) N6-disubstituierte purinderivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel.
WO2007125321A3 (en) Purine and deazapurine derivatives as pharmaceutical compounds
TW200505874A (en) New compounds with therapeutic effect
TW200716528A (en) Cyclopropanecarboxamide derivatives
MY118904A (en) 4-oxo-1, 4-dihydro-3-quinolinecarboxamides as antiviral agents
NZ602099A (en) Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient
RU92016545A (ru) Гетероциклические соединения, способ их получения и фармацевтическая композиция
NZ314406A (en) Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles
PH31303A (en) Piperazine derivatives.
HU911992D0 (en) 2-(amino-alkyl)-5-(aryl-alkyl)-1,3-dioxanes, and process for the production of the medical preparations containing them
PL316964A1 (en) O-acyl 4-phenyl cyclohexanol, yheir salts, therapeutic agents containing such compound as well as their application and method of obtaining them
NZ501785A (en) 4-(3,4-dihydro-2-naphthylmethyl)- or 4-(2H-3-chromenylmethyl)-4,5-dihydro-1H-imidazole derivatives
HUP0303512A2 (hu) Biuretánszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
SU1593568A3 (ru) Cпocoб пoлучehия пpoизboдhыx 4-(4-aлkилфehил)-tиaзoл-2-илa
HU895522D0 (en) Process for the preparation of new thienyl-oxy-alkyl-amine derivatives and pharmaceutical compositions containing them
SE9702534D0 (sv) Compounds
KR880012587A (ko) 치환된 퀴녹살릴-이미다졸리딘-2,4-디온, 이의 제조 방법, 및 약제 및 약제학적 제제로서의 이의 용도
NO159018C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive disubstituerte polymetyleniminer.
GR3023144T3 (en) Inhibitors of pneumocystis carinii dihydrofolate reductase
HUP9802543A2 (hu) Eljárás nem inzulinfüggő diabetes mellitusban szenvedő betegek esetében az adagolt exogén inzulin mennyiségének csökkentésére alkalmas tiazolindion-származékokat tartalmazó gyógyszerkészítmények előállítására
ATE167873T1 (de) Neue heterocyclische acyldipeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung
TW355184B (en) Substituted thiophenylsulfonylureas and -thioureas, process for their preparation, their use as a medicament or diagnostic, and medicament containing them

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees